Search - tctmd.com

Displaying 161 - 180 of 244

Sort: Relevancy | Date

News Daily News

Los Datos de Registro Sugieren Protección Hasta 2 Años con el Cierre del AAI

Caitlin E. Cox

January 28, 2015

News Daily News

Hospital Volume Linked to More Favorable LAA Closure Outcomes

Todd Neale

December 11, 2014

News Daily News

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Caitlin E. Cox

November 19, 2014

News Daily News

对房颤患者使用Amplatzer进行LAA封堵显得安全、有效

Yael L. Maxwell

November 06, 2014

News Daily News

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Yael L. Maxwell

November 06, 2014

News Daily News

El Cierre del AAI con Amplatzer parece Seguro y Eficaz en Pacientes con FA

Yael L. Maxwell

November 06, 2014

News Daily News

得到的FDA专家组支持率低，Watchman可能为时不多了

L.A. McKeown

October 16, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

Presentation TCT 2014

TCT 175: Preclinical Study of the Novel Generation of Watchman for Left Atrial Appendage Occlusion

Presenter: Josep Rodés-Cabau, Peter B Sick, Krzysztof Bartus, Dongming Hou

September 16, 2014

Presentation TCT 2014

Watchman Step-by-Step

Presenter: Saibal Kar, Horst Sievert, Jochen Wöhrle

September 16, 2014

Presentation TCT 2014

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Presenter: George Hanzel

September 16, 2014

Presentation TCT 2014

TCT 171: Avoidance of Major Bleeding with WATCHMAN Left Atrial Appendage Closure Compared with Long-term Oral Anticoagulation: A Pooled Analysis of Randomized Trials

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Matthew J. Price

September 15, 2014

Presentation TCT 2014

Yes, It Is a Good Option for Most Anticoagulation Eligible Patients

Presenter: Saibal Kar

September 15, 2014

Presentation TCT 2014

No, It Should Be Limited to Patients with Absolute Anticoagulation Contraindications

Presenter: Jai-Wun Park

September 15, 2014

Presentation TCT 2014

Watchman II: PROTECT-AF/PREVAIL Meta-analysis and Implications

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, David R. Holmes Jr.

September 15, 2014

Presentation TCT 2014

Watchman I: First Report of the 5-Year PROTECT-AF and Extended PREVAIL Results

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Vivek Y. Reddy

September 15, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

Presentation TCT 2014

Watchman Nightmare Case and Teaching Moment #2: Improper Device Sizing with Embolization

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, Vivek Y. Reddy

September 13, 2014

Presentation TCT 2014

Watchman Nightmare Case and Teaching Moment #1: A Perforation

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, Maurice Buchbinder

September 13, 2014

Presentation TCT 2014

LAA Closure with the Watchman Device: A Perfect Case (Step-by-Step)

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, Ramon Quesada

September 13, 2014

Advertisement

Los Datos de Registro Sugieren Protección Hasta 2 Años con el Cierre del AAI

Hospital Volume Linked to More Favorable LAA Closure Outcomes

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

对房颤患者使用Amplatzer进行LAA封堵显得安全、有效

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

El Cierre del AAI con Amplatzer parece Seguro y Eficaz en Pacientes con FA

得到的FDA专家组支持率低，Watchman可能为时不多了

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

TCT 175: Preclinical Study of the Novel Generation of Watchman for Left Atrial Appendage Occlusion

Watchman Step-by-Step

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

TCT 171: Avoidance of Major Bleeding with WATCHMAN Left Atrial Appendage Closure Compared with Long-term Oral Anticoagulation: A Pooled Analysis of Randomized Trials

Yes, It Is a Good Option for Most Anticoagulation Eligible Patients

No, It Should Be Limited to Patients with Absolute Anticoagulation Contraindications

Watchman II: PROTECT-AF/PREVAIL Meta-analysis and Implications

Watchman I: First Report of the 5-Year PROTECT-AF and Extended PREVAIL Results

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Watchman Nightmare Case and Teaching Moment #2: Improper Device Sizing with Embolization

Watchman Nightmare Case and Teaching Moment #1: A Perforation

LAA Closure with the Watchman Device: A Perfect Case (Step-by-Step)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content